Gamma Medica

company

About

Gamma Medica offers LumaGEM® MBI System, an FDA-cleared dual-headed digital imaging system.

  • 11 - 50

Details

Last Funding Type
Series B
Last Funding Money Raised
$11.50M
Industries
Biotechnology,Health Care,Pharmaceutical
Founded date
Jan 1, 2013
Number Of Employee
11 - 50
Operating Status
Active

Gamma Medica, Inc. is proud to offer the LumaGEM® MBI System. As the first commercially available, FDA cleared, planar, dual head, fully solid state digital imaging system utilizing cadmium zinc telluride (CZT) technology used for breast imaging, LumaGEM is able to detect millimeter-size breast cancers missed by mammography, especially in women with dense breast tissue.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$11.50M
Gamma Medica has raised a total of $11.50M in funding over 2 rounds. Their latest funding was raised on Oct 22, 2014 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 22, 2014 Series B $11.50M 1 Hercules Capital Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Gamma Medica is funded by 1 investors. Hercules Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Hercules Capital Yes Series B